Klaus DUGI,Eva Ulrike GRAEFE-MODY,Ruth HARPER,Hans-Juergen WOERLE
申请号：
US15287228
公开号：
US20170020868A1
申请日:
2016.10.06
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for treating and/or preventing metabolic diseases, particularly diabetes, in patients for whom metformin therapy is inappropriate due to intolerability or contraindication against metformin.
